Share this:
Kelsey Mohring
@kelseydm

Posts: 299
Joined: Feb 24, 2015

Exciting news from the Jacksonville, Florida Mayo Clinic where researchers have gained [...]

Posted by @kelseydm, May 18, 2015

Exciting news from the Jacksonville, Florida Mayo Clinic where researchers have gained a mouse model for testing potential amyotrophic lateral sclerosis (ALS) treatments. ALS or Lou Gehrig’s disease is associated with various behavioral features and neuropathological symptoms as is frontotemporal dementia (FTD); both are caused by a mutation in the C9ORF72 gene. Both result in the death of neurons in the spinal cord and brain, which leads to inability to control muscles, paralysis, and death. The team expects that these results will hasten research into the molecular mechanism for ALS and FTD, and that potential therapeutic agents can be tested using this animal model.

COMMENT

Please login or register to post a reply.